SARS-CoV-2 Variant Under Investigation 202012/01 has more than twofold replicative advantage
medRxiv（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined